Biotech stocks are having a big day Friday, helping to almost erase the sector's under-performance in the fourth quarter.
Take a look at where we stand:
Why the big rebound? Biogen Idec (BIIB - Get Report) and Gilead Sciences (GILD - Get Report) are certainly helping. Both received positive news from European regulators Friday, which seems to have triggered another round of buying.
-- Reported by Adam Feuerstein in Boston.
Follow Adam Feuerstein on Twitter.